Detalhe da pesquisa
1.
A narrative commentary about interoperability in medical devices and data used in diabetes therapy from an academic EU/UK/US perspective.
Diabetologia
; 67(2): 236-245, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38041737
2.
Molecular mechanisms linking type 2 diabetes mellitus and late-onset Alzheimer's disease: A systematic review and qualitative meta-analysis.
Neurobiol Dis
; 196: 106485, 2024 Apr 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-38643861
3.
Hypoglycaemia symptom frequency, severity, burden, and utility among adults with type 1 diabetes and impaired awareness of hypoglycaemia: Baseline and 24-week findings from the HypoCOMPaSS study.
Diabet Med
; 41(1): e15231, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-37746767
4.
Cost-effectiveness of a Novel Hypoglycaemia Programme: The 'HARPdoc vs BGAT' RCT.
Diabet Med
; 41(6): e15304, 2024 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38421806
5.
Intermittently scanned continuous glucose monitoring and hypoglycaemia awareness in drivers with diabetes: Insights from the Association of British Clinical Diabetologists Nationwide audit.
Diabetes Obes Metab
; 26(1): 46-53, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-37718554
6.
Changes in attitudes to awareness of hypoglycaemia during a hypoglycaemia awareness restoration programme are associated with avoidance of further severe hypoglycaemia episodes within 24 months: the A2A in HypoCOMPaSS study.
Diabetologia
; 66(4): 631-641, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36538062
7.
UK's Association of British Clinical Diabetologist's Diabetes Technology Network (ABCD-DTN): Best practice guide for hybrid closed-loop therapy.
Diabet Med
; 40(7): e15078, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-36932929
8.
Addressing health inequalities in diabetes through research: Recommendations from Diabetes UK's 2022 health inequalities in diabetes workshop.
Diabet Med
; 40(4): e15024, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36508339
9.
Impact of glycaemic technologies on quality of life and related outcomes in adults with type 1 diabetes: A narrative review.
Diabet Med
; 40(1): e14944, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36004676
10.
CGM accuracy: Contrasting CE marking with the governmental controls of the USA (FDA) and Australia (TGA): A narrative review.
Diabetes Obes Metab
; 25(4): 916-939, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36585365
11.
Continuous glucose monitoring-based time-in-range using insulin glargine 300 units/ml versus insulin degludec 100 units/ml in type 1 diabetes: The head-to-head randomized controlled InRange trial.
Diabetes Obes Metab
; 25(2): 545-555, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36263928
12.
Twelve-month results of the ADAPT randomized controlled trial: Reproducibility and sustainability of advanced hybrid closed-loop therapy outcomes versus conventional therapy in adults with type 1 diabetes.
Diabetes Obes Metab
; 25(11): 3212-3222, 2023 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37551542
13.
Beta-cell death and dysfunction drives hyperglycaemia in organ donors.
Diabetes Obes Metab
; 25(12): 3529-3537, 2023 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37646197
14.
A Roadmap to an Equitable Digital Diabetes Ecosystem.
Endocr Pract
; 29(3): 179-184, 2023 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-36584818
15.
Intermittent Use of Continuous Glucose Monitoring: A New Paradigm in Treatment of Type 2 Diabetes.
J Assoc Physicians India
; 71(6): 11-12, 2023 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-37355844
16.
Characteristics of adults with type 1 diabetes and treatment-resistant problematic hypoglycaemia: a baseline analysis from the HARPdoc RCT.
Diabetologia
; 65(6): 936-948, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35325258
17.
The impact of islet mass, number of transplants, and time between transplants on graft function in a national islet transplant program.
Am J Transplant
; 22(1): 154-164, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34355503
18.
Current provision and HCP experiences of remote care delivery and diabetes technology training for people with type 1 diabetes in the UK during the COVID-19 pandemic.
Diabet Med
; 39(4): e14755, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-34862815
19.
Choosing the duration of continuous glucose monitoring for reliable assessment of time in range: A new analytical approach to overcome the limitations of correlation-based methods.
Diabet Med
; 39(5): e14758, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-34862829
20.
Individual, healthcare professional and system-level barriers and facilitators to initiation and adherence to injectable therapies for type 2 diabetes: A systematic review and meta-ethnography.
Diabet Med
; 39(1): e14678, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34432914